AstraZeneca PLC (NASDAQ:AZN)
| 67.43 Delayed Data As of Sep 28 |  -0.51 / -0.75%Today’s Change | 53.24 Today|||52-Week Range 76.56 | -0.55% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $210.3B |
Company Description
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Contact Information
AstraZeneca PLC Cambridge Biomedical Campus Cambridge Cambridgeshire CB2 0AA |
Employees
Shareholders
| Mutual fund holders | 9.38% |
| Other institutional | 6.62% |
| Individual stakeholders | -- |
Top Executives
| Pascal Soriot | Chief Executive Officer & Executive Director |
| Pam P. Cheng | Executive VP-Operations & Information Technology |
| Aradhana Sarin | Chief Financial Officer & Executive Director |
| Cindy L. Hoots | Chief Digital & Information Officer |
| Alberto Hegewisch | Chief Medical Officer |